Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
Following Trump’s lunch with artificial intelligence leaders at the White House, the industry remains largely unchanged on AI safety.
Deutsche Bank CEO Christian Sewing warned that recent election results could hurt Germany’s appeal to international investors.
The Senate will vote on bills that would ban members from trading stocks while in office, and to address data center-related utility costs, amid Democratic opposition.
Candidates can use AI to create endless resumes and cover letters. It’s forcing businesses to rethink how they hire.
U.S. President Donald Trump has denied reports that he had offered sanctions relief to Iran in exchange for concessions from Tehran on its nuclear program.
Unusual trading patterns on Kalshi and Polymarket are drawing scrutiny as experts debate whether reported volumes reflect organic market activity.
Following Meta’s blockbuster release of its Muse AI agent earlier this month, OpenAI jumped into the personal agent market with Dots.
English soccer club Manchester City has been found guilty of breaking Premier League financial rules over nine seasons.
Private job creation picked up in September after a brief slowdown.